tert-Butyl (3-(aminomethyl)cyclobutyl)carbamate

Catalog No. :
ACQWPZ749
CAS No. :
130369-10-7
Molecular Formula :
C10H20N2O2
Molecular Weight :
200.28

IUPAC Name:tert-butyl (3-(aminomethyl)cyclobutyl)carbamate

tert-Butyl (3-(aminomethyl)cyclobutyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$277.00Login to see priceIn stockInquiry
250mg95%$442.00Login to see priceInquiryInquiry
500mg95%$734.00Login to see priceInquiryInquiry
1g95%$1099.00Login to see priceInquiryInquiry
5g95%$3297.00Login to see priceInquiryInquiry
10g95%$5494.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-(aminomethyl)cyclobutyl)carbamate
IUPAC Nametert-butyl (3-(aminomethyl)cyclobutyl)carbamate
MDL No.MFCD17392592
Molecular FormulaC10H20N2O2
Molecular Weight200.28
SMILESO=C(OC(C)(C)C)NC1CC(CN)C1
InChI KeyACDLXPYQWYTZLE-UHFFFAOYSA-N
Synonym130369-10-7 | tert-Butyl (3-(aminomethyl)cyclobutyl)carbamate | 1214727-57-7 | 871014-28-7 | TRANS-TERT-BUTYL (3-(AMINOMETHYL)CYCLOBUTYL)CARBAMATE | CIS-TERT-BUTYL (3-(AMINOMETHYL)CYCLOBUTYL)CARBAMATE | TERT-BUTYL N-[3-(AMINOMETHYL)CYCLOBUTYL]CARBAMATE | tert-Butyl (tr
CAS No.130369-10-7
PubChem CID19794315

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQWPZ749 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQWPZ749 route product structure diagram
    ACQWPZ749130369-10-7 In Stock
Inquiry

2. ACQWPZ749 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQWPZ749 route product structure diagram
    ACQWPZ749130369-10-7 In Stock
Inquiry

Comments (0)